TransMedics Group, Inc. — Director's Dealing 2023

Jul 17, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2023-07-13

Reporting Person: Khayal Tamer I (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-07-13	Common Stock	M	2974	$16.14	Acquired	17349	Direct
2023-07-13	Common Stock	S	2974	$90.05	Disposed	14375	Direct
2023-07-13	Common Stock	S	2225	$90.02	Disposed	14776	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-07-13	Stock Option (Right to Buy)	$16.14	M	2974	Disposed	2030-02-27	Common Stock (2974)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	11051	Indirect

Footnotes

F1: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 2, 2022.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $90.00 to $90.23, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3: Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F4: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on December 12, 2022.

F5: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $90.00 to $90.23, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range

F6: The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020.